November 20, 2026 | Sacramento, CA — MedLegalNews.com — Workers compensation prescription disputes remained a significant part of California’s medical treatment authorization system during the first nine months of 2026, with pharmaceutical requests accounting for 30.8% of all Independent Medical Review decisions. New data from the California Workers’ Compensation Institute (CWCI) show that medication-related requests represented the largest category of IMR activity between January and September, exceeding the shares attributed to physical therapy and injections. The findings highlight the continuing role of prescription treatment in workers’ compensation disputes and the importance of documenting medical necessity when medication requests are challenged through utilization review.
The CWCI findings provide a useful measure of where treatment authorization disagreements are concentrated, but the percentage should be interpreted carefully. The 30.8% figure represents the proportion of IMR decisions involving pharmaceutical requests, not the percentage of all prescription requests that were denied or the proportion of injured workers whose medications were rejected. Independent Medical Review generally becomes relevant after a utilization review decision is disputed through the applicable process. The data therefore describe the composition of reviewed disputes rather than every medication prescribed or requested across California’s workers’ compensation system. Understanding that distinction is essential when evaluating the implications of workers compensation prescription disputes for injured workers, treating physicians, claims administrators, and medical-legal professionals.
Pharmaceutical Requests Represent the Largest Share of IMR Decisions
According to CWCI, pharmaceutical requests accounted for 30.8% of California IMR decisions during the January–September 2026 reporting period. Physical therapy represented 13.2%, while injections accounted for 12.8%. These figures establish a notable difference between medication-related disputes and other frequently contested treatment categories. Although physical therapy and injection requests remain important components of workers’ compensation medical care, pharmaceutical treatment generated a substantially larger share of the decisions reviewed during the period. The distribution suggests that medication authorization continues to be a major area of disagreement within the utilization review and independent medical review framework.
The figures do not establish why pharmaceutical requests account for the largest share of disputes. They do, however, identify prescription treatment as an important subject for further examination of medical necessity, prescribing practices, treatment documentation, and utilization review decisions. Medication requests can involve questions about the diagnosis being treated, the purpose of a particular drug, the duration of therapy, the prescribed dosage, potential adverse effects, and whether the treatment is consistent with applicable evidence-based medical standards.
When these issues are not adequately explained in the medical record, disagreements may arise between the treating physician’s recommendation and the utilization review determination. The CWCI distribution therefore provides a reason to examine the documentation and clinical reasoning that support prescription requests in California workers’ compensation cases.
Medical Necessity and Documentation in Prescription Authorization
Medical necessity is central to evaluating prescription treatment requests in workers’ compensation cases. A medication request should be supported by clinical information that explains the condition being treated, the relationship between the medication and the industrial injury, and the anticipated therapeutic purpose. The treating physician’s documentation may also need to address the patient’s response to previous treatment, the effectiveness of the current medication regimen, and the clinical reasons for initiating, continuing, changing, or discontinuing a prescription. A medication name or dosage alone may not communicate the full reasoning behind a treatment recommendation. Clear documentation helps reviewers understand how the requested medication fits into the patient’s overall treatment plan.
For workers compensation prescription disputes, the medical record can become particularly important when the requested medication involves ongoing treatment, multiple prescriptions, or a change in the patient’s clinical circumstances. Relevant documentation may include examination findings, the patient’s reported symptoms, functional limitations, treatment history, medication response, and the physician’s assessment of whether continued use is appropriate. Where applicable, the record should also explain why alternative treatments may not provide comparable clinical benefit or why a particular medication remains necessary. These details do not guarantee authorization, but they provide a more complete clinical basis for evaluating the request. Consistent documentation also helps distinguish a medically supported treatment recommendation from a request that lacks sufficient explanation of its purpose or necessity.
Evidence-Based Prescribing and Utilization Review Standards
Evidence-based prescribing is an important consideration when medication requests are evaluated through utilization review. California’s workers’ compensation medical treatment framework relies on applicable medical treatment guidelines and standards to assess whether proposed care is appropriate for an injured worker’s condition. Reviewers may consider whether the requested medication is consistent with the relevant treatment recommendations, whether the clinical record supports its use, and whether the proposed treatment is appropriate in light of the patient’s medical circumstances. The assessment is not simply a question of whether a medication is commonly prescribed. It involves the relationship between the patient’s documented condition, the treatment objective, and the available clinical justification.
Treating physicians also have a responsibility to communicate the reasoning behind prescription decisions in a way that can be evaluated by utilization review professionals. When a medication request differs from a guideline recommendation or requires an individualized treatment approach, the supporting medical record may need to explain the clinical circumstances that justify the recommendation. This can include the patient’s response to prior medications, contraindications, treatment failures, or other relevant factors.
Evidence-based prescribing does not mean that every patient must receive identical treatment. Rather, it provides a framework for evaluating clinical decisions while allowing patient-specific circumstances to be considered. In workers compensation prescription disputes, a clearly documented explanation of those circumstances can help reviewers assess the medical basis of the requested treatment.
Implications for Injured Workers, Physicians, and Claims Administrators
The concentration of pharmaceutical requests within IMR decisions has implications for injured workers because medication access can affect pain management, symptom control, rehabilitation, and the ability to participate in daily activities. When a prescription request is modified or denied through utilization review, the resulting dispute may create uncertainty about whether a patient can continue an existing medication or begin a proposed treatment. The IMR process provides a mechanism for reviewing qualifying medical necessity disputes, but the CWCI data do not establish how long individual patients waited for decisions or whether a particular dispute resulted in a treatment interruption.
Those outcomes require separate evidence. Nevertheless, the large share of pharmaceutical requests in the reported IMR activity demonstrates why medication authorization remains an important issue for workers’ compensation stakeholders.
For treating physicians and claims administrators, the findings reinforce the importance of accurate, complete, and timely communication throughout the treatment authorization process. Physicians can support appropriate review by documenting the diagnosis, treatment objectives, medication history, clinical response, and reasons for the requested prescription. Claims administrators and utilization review organizations must evaluate requests under the applicable standards and consider the clinical information submitted. Medical-legal professionals may also encounter prescription authorization issues when reviewing treatment histories, assessing the progression of an injury, or evaluating the relationship between medical care and reported functional limitations.
The CWCI report does not establish that one participant group is responsible for the volume of disputes. Instead, it identifies pharmaceutical treatment as a substantial area in which clear clinical documentation and consistent application of medical treatment standards remain important.
Understanding the Limits of the 2026 IMR Findings
The CWCI report offers a snapshot of California workers’ compensation IMR activity during the first nine months of 2026. Its finding that pharmaceutical requests represented 30.8% of decisions provides a useful comparison with physical therapy at 13.2% and injections at 12.8%. However, the percentages should not be interpreted as a complete measure of prescription authorization outcomes across the state. IMR decisions represent disputes that reached the independent review process, not the total number of medication requests submitted, approved, modified, or denied through utilization review. The reported distribution also does not, by itself, identify the clinical reasons behind individual decisions or establish whether particular medications were more likely to be disputed than others.
Additional information would be necessary to determine which pharmaceutical categories contributed most to the reported share, what clinical circumstances commonly prompted disputes, and whether the distribution changed significantly across different medication types. A more detailed assessment could also examine the relationship between prescription disputes, treatment duration, prescribing patterns, and the medical documentation submitted during review. Until those details are available, the 30.8% figure is best understood as an indicator of the prominence of pharmaceutical requests within IMR activity rather than proof of a broader prescribing or authorization problem.
Continued monitoring of CWCI data and California’s medical treatment review framework can help stakeholders evaluate whether medication-related disputes are changing and what those changes may mean for injured workers and the professionals responsible for their care.
Conclusion: Prescription Authorization Remains a Major Medical-Legal Issue
The 2026 CWCI findings identify prescription treatment as the largest category of California workers’ compensation IMR decisions during the first nine months of the year. With pharmaceutical requests accounting for 30.8% of reviewed decisions, workers compensation prescription disputes remain a significant subject for physicians, claims administrators, injured workers, and medical-legal professionals. The comparison with physical therapy and injections further demonstrates that medication authorization represents a substantial portion of the treatment disagreements reaching independent review.
The findings also reinforce the importance of medical necessity documentation and evidence-based prescribing in the California workers’ compensation system. The data do not establish that all prescription requests are being denied or that the reported share reflects the overall approval rate for medications. They do show that pharmaceutical treatment is frequently represented in IMR decisions, making accurate clinical records and clear treatment justifications important parts of the authorization process. As additional reporting becomes available, stakeholders will have more information to assess the direction of medication-related disputes and their implications for medical care in California workers’ compensation.
For the underlying findings and reporting details, consult the California Workers’ Compensation Institute’s report, CWCI: California Workers’ Comp IMR Activity Dips for First Time Since 2022.
Follow MedLegalNews.com for accurate, timely coverage of California workers’ compensation medical-legal developments, treatment authorization standards, independent medical review, physician issues, and regulatory changes affecting injured workers and the professionals who serve them. Subscribe to MedLegalNews.com for continuing updates and analysis.
🔗 Read More from MedLegalNews.com:
- California QME Certification Process Raises Questions About Medical-Legal Evaluation Capacity
- California Workers’ Comp Deposition Fee Proposal Draws Criticism From Both Sides
- Massachusetts Talc Verdict Highlights the Importance of Causation Evidence in Mesothelioma Litigation
- Washington’s $900 Million Albertsons Judgment Raises New Questions About Opioid Dispensing Oversight
- California Workers’ Compensation Drug Treatment Oversight Enters October Review
FAQs: Workers Compensation Prescription Disputes
Why do prescription requests account for a large share of California workers’ compensation IMR decisions?
The CWCI report found that pharmaceutical requests represented 30.8% of IMR decisions during the first nine months of 2026. This makes medications the largest treatment category in the reported distribution. The data identify the volume of pharmaceutical-related decisions but do not establish the specific reasons behind each dispute.
What is the difference between utilization review and Independent Medical Review?
Utilization review evaluates whether requested medical treatment is medically necessary under applicable standards. Independent Medical Review provides an external review mechanism for qualifying disputes involving utilization review decisions. The two processes serve different functions within California’s workers’ compensation medical treatment authorization system.
What documentation can support a workers’ compensation prescription request?
Relevant documentation may include the patient’s diagnosis, examination findings, treatment history, medication response, functional limitations, and the physician’s explanation of the medication’s therapeutic purpose. The record should provide enough clinical information to explain why the requested prescription is appropriate for the patient’s circumstances.
Does the 30.8% figure mean that 30.8% of prescription requests were denied?
No. The figure represents the share of IMR decisions involving pharmaceutical requests. It does not represent the percentage of all prescription requests denied, the overall medication denial rate, or the proportion of injured workers who experienced a prescription dispute.
